Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Edler

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Onkologie|April 1, 1990
Statistical requirements of phase I studiesL Edler
Annals of the New York Academy of Sciences|February 17, 2000
Uncertainty in biomonitoring and kinetic modelingL Edler
Human & Experimental Toxicology|August 29, 2009
3.2 Quantification of uncertainty within and between species and the role of uncertainty factorsL Edler
Human & Experimental Toxicology|August 29, 2009
4.4 The proposed replacement of the no observed adverse effect level with benchmark dose levels in food risk assessmentL Edler
Mutation Research|July 1, 1992
Statistical methods for short-term tests in genetic toxicology: the first fifteen yearsL Edler
Environmental Health Perspectives|January 1, 1994
Biostatistical issues in the design and analysis of multiple or repeated genotoxicity assaysL Edler
Onkologie|December 1, 1987
[Remission in phase II and phase III studies: criteria and prerequisites]L Edler, H Flechtner
Controlled Clinical Trials|March 1, 1987
A sample size program for "proving the null hypothesis"C Heiselbetz, L Edler
Onkologie|January 8, 2004
Randomized clinical trial: myths around elementary statistical principlesL Edler, A Kopp-Schneider
Mutation Research|September 28, 1998
Statistical models for low dose exposureL Edler, A Kopp-Schneider
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Onkologie|April 1, 1990
Statistical requirements of phase I studiesL Edler
Annals of the New York Academy of Sciences|February 17, 2000
Uncertainty in biomonitoring and kinetic modelingL Edler
Human & Experimental Toxicology|August 29, 2009
3.2 Quantification of uncertainty within and between species and the role of uncertainty factorsL Edler
Human & Experimental Toxicology|August 29, 2009
4.4 The proposed replacement of the no observed adverse effect level with benchmark dose levels in food risk assessmentL Edler
Mutation Research|July 1, 1992
Statistical methods for short-term tests in genetic toxicology: the first fifteen yearsL Edler
Environmental Health Perspectives|January 1, 1994
Biostatistical issues in the design and analysis of multiple or repeated genotoxicity assaysL Edler
Onkologie|December 1, 1987
[Remission in phase II and phase III studies: criteria and prerequisites]L Edler, H Flechtner
Controlled Clinical Trials|March 1, 1987
A sample size program for "proving the null hypothesis"C Heiselbetz, L Edler
Onkologie|January 8, 2004
Randomized clinical trial: myths around elementary statistical principlesL Edler, A Kopp-Schneider
Mutation Research|September 28, 1998
Statistical models for low dose exposureL Edler, A Kopp-Schneider
Pageof 13